Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) EPS (Weighted Average and Diluted) (2019 - 2025)

Amicus Therapeutics filings provide 7 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.01 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 89.04% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.09, a 50.0% increase, with the full-year FY2025 number at -$0.09, up 50.0% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.01 in Q4 2025 for Amicus Therapeutics, down from $0.06 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q3 2025 to a low of -$0.31 in Q4 2021.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.1 (2023), compared with a mean of -$0.11.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 400.0% in 2025, down 89.04% in 2025.
  • Amicus Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.31 in 2021, then surged by 37.01% to -$0.19 in 2022, then skyrocketed by 43.08% to -$0.11 in 2023, then surged by 145.45% to $0.05 in 2024, then tumbled by 89.04% to $0.01 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.01 (Q4 2025), $0.06 (Q3 2025), and -$0.08 (Q2 2025) per Business Quant data.